Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
LM-24C5 by LaNova Medicines for Solid Tumor: Likelihood of Approval
LM-24C5 is under clinical development by LaNova Medicines and currently in Phase II for Solid Tumor. According to GlobalData, Phase...